Thermo Fisher agrees to sell microbiology business to Astorg in $1bn deal
Summary
According to GlobalData analyst Dr Andrew S Thompson, the deal signals Thermo Fisher’s move away from the IVD space.
Description
According to GlobalData analyst Dr Andrew S Thompson, the deal signals Thermo Fisher’s move away from the IVD space.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source